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UNIT A3.2Metastatic Extra-Axial Neoplasia
There are a multitude of tumors which may spread to the extra-axial compartment (i.e.,
meninges, skull base, and calvarium). The role of imaging in the search for metastases is
to detect the full extent of and to correctly localize the disease. This unit presents the set
of MR sequences (see Basic Protocols 1, 2, and 3) used for imaging extra-axial metastatic
tumors, and specific modifications will be discussed where necessary. The sequences
described in this unit are based on the authors’ experience with a 1.5 T scanner (Echospeed
GE Medical Systems, Milwaukee, Wisconsin), but can be expected to be equally appli-
cable to other field strengths and scanners from other manufacturers.
BASIC
PROTOCOL 1
RULE OUT (R/O) LEPTOMENINGEAL CARCINOMATOSIS
Spread of tumor to the leptomeninges is frequently seen in association with any adeno-
carcinoma (i.e., breast, lung, gastrointestinal tumors) and lymphoma or leukemia (Gold-
berg et al., 1996). MR imaging in suspected leptomeningeal carcinomatosis is essential
not only to demonstrate the disease, but also to assess for potential complications
including hydrocephalus. The post-gadolinium T1-weighted images and fluid-attenuated
inversion recovery (FLAIR) images are most useful when evaluating spread of tumor,
particularly along the subarachnoid space (leptomeninges; Singer et al., 1998). Sequences
1 to 5 comprise the preferred protocol.
Table A3.2.1 lists the hardware necessary to perform the procedure, along with appropri-
ate parameters.
NOTE: Be sure that technologists and nurses have immediate access to any equipment
such as crash carts or oxygen that may be necessary in the event of an emergency. Contrast
reactions are rare, but the resources are necessary.
Materials
Normal saline (0.9% NaCl), sterile
Intravenous contrast agent (e.g., Magnevist, Omniscan, or Prohance)
Set up equipment and patient
1. Interview (screen) the patient to ensure that he or she has no contraindications to the
MRI examination, such as a cardiac pacemaker or other implants or foreign bodies
containing ferromagnetic materials. Question the patient regarding any health con-
ditions that may require the presence of specific emergency equipment during the
scanning procedure, or necessitate any other precautions.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system.
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Table A3.2.1 Equipment Parameters for Imaging Brain Tumors
Coil type Quadrature head coil
Gradient coil strength 25 mT/m (or whatever the system permits)
Cardiac gating No
Peripheral gating For safety only
Respiratory gating No
Respirator If required by patient
Oxygen If required by patient
Motion cushions No
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The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience in the magnet, and how to behave, including the following:
a. Ear protection will be provided (earphones, headphones, earplugs) to dampen the
sounds from the gradients, but the patient will be able to communicate with you
at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results the patient should not talk, and should avoid or minimize
swallowing or other movement, during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. Help the patient mount onto the table and lie in the supine position. Set up all
monitoring equipment or any triggering devices before or right after the patient lies
down.
7. Center the patient in the head coil at the region where the key information is desired.
Make sure the head and neck are constrained to prevent motion.
Generally the patient’s head is fixed so that the head is horizontal (not tilted) and the neck
and head lie along the axis of the patient table.
8. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
9. Use the centering light to position the patient (centered on the nasion) and put him
or her into the center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
10. If the patient is unable to hold still, provide an appropriate sedative.
Sequence 1: Localizer
11. Run sequence 1 according to Table A3.2.2. The sagittal scout view is used to prescribe
the transverse and coronal sequences.
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Table A3.2.3 Primary Clinical Imaging Parameters for T1-Weighted Scan
(Sequence 2)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 11 msec (or select “minimum
full” echo time)
Receiver bandwidth (RBW) 10 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 or as many as needed to cover
the region of interest
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time 1 min, 28 sec
Table A3.2.2 Primary Clinical Imaging Parameters for T1-Weighted Scan
(Sequence 1 Localizer)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Laser light centered on nasion
Echo time (TE) 11 msec (or select “minimum
full” echo time)
Receiver bandwidth (RBW) 10 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 or as many as needed to cover
the region of interest
Slice gap 2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Saturation pulses Not applicable
Scan time 1 min, 28 sec
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Table A3.2.5 Primary Clinical Imaging Parameters for Fast FLAIR Scan
(Sequence 4)
Patient position Supine
Scan type Inversion recovery fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 120 msec (effective)
Receiver bandwidth (RBW) 16 kHz
Echo train length (ETL) 8
Repeat time (TR) 10000 msec
Inversion time (TI) 2200 msec
Flip angle (FA) 180°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 or as many as needed to cover
the region of interest
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time ∼5 min
Table A3.2.4 Primary Clinical Imaging Parameters for T2-Weighted Scan
(Sequence 3)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 102 msec (effective)
Receiver bandwidth (RBW) 16 kHz
Echo train length (ETL) 8
Repeat time (TR) 3600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 or as many as needed to cover
the region of interest
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time ∼2 min
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Sequence 2: T1-weighted scan
12. Run sequence 2 according to Table A3.2.3. The pre-contrast T1-weighted scan should
be acquired in the same plane as the post-contrast T1-weighted scan to look for
intra-lesional enhancement.
Sequence 3: T2-weighted scan
13. Run sequence 3 according to Table A3.2.4.
Sequence 4: Fast fluid-attenuated inversion recovery (FLAIR) scan
14. Run sequence 4 according to Table A3.2.5. FLAIR images are useful when evaluating
spread of tumor, particularly along the subarachnoid space (leptomeninges).
Sequence 5: Post-contrast imaging
15. Remove the patient from the scanner. The patient should not move on the table.
Establish an intravenous line from which the contrast agent can be injected, and attach
this line securely to the patient so that movement into or out of the magnet will not
pull at the patient’s arm. Move the patient back into the scanner.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet,
with no intervening motion, between the scans run before contrast agent injection and those
run after injection.
16. Leaving the patient in the magnet, inject the contrast agent, flush the line with 10 ml
saline.
A dose of 0.1 mmol/kg of contrast agent is usually given.
A delay in scanning may actually be beneficial when evaluating for metastases, which is
one of the reasons we scan in multiple planes after intravenous contrast administration.
17. Acquire the post-contrast images using the same parameters as in sequence 2
(T1-weighted), Table A3.2.3. In addition to the transverse plane, the coronal plane is
routinely obtained, with the following changes to the parameters in sequence 2: (a)
flow compensation is on; (b) TE is 15 msec (prolonged due to flow compensation
gradients); and (c) it is not necessary to swap read and phase encoding directions. We
also routinely obtain a third post-contrast plane of imaging (sagittal) in patients
requiring sedation and in all pediatric patients.
BASIC
PROTOCOL 2
R/O BASE OF SKULL METASTASIS
Metastases to the base of the skull frequently arise from the local spread of pharyngeal
tumor, or from hematogenous spread to the bone. The main purpose of imaging is to
demonstrate disease and determine the full extent of spread of the lesion (i.e., cranial
nerve or meningeal involvement). Fat-suppressed high-resolution imaging (including
T2-weighted imaging and post-contrast T1-weighted imaging) is essential when evaluating
tumor involvement of skull base structures.
Set up patient and equipment
1. Use the same equipment and perform equipment and patient setup as for the previous
method (see Basic Protocol 1).
2. Obtain sequences 1, 2, 3 outlined in Basic Protocol 1 to evaluate the entire brain.
3. For high-resolution imaging of the skull base, perform transverse pre-contrast se-
quences 6 and 7 outlined in Tables A3.2.6 and A3.2.7. The entire extent of the lesion
must always be included.
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Table A3.2.6 Primary Clinical Imaging Parameters for T2-Weighted Scan
(Sequence 6)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 102 msec (effective)
Receiver bandwidth (RBW) 16 kHz
Echo train length (ETL) 16
Repeat time (TR) 4000 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.70 mm
Number of data points collected (Nx, Ny) 256, 256
Slice thickness (∆z) 3 mm
Number of slices 20 or as many as needed to cover
entire skull base
Slice gap 0.5 mm
Number of acquisitions (Nacq) 3
Swap read and phase encoding Yes
Saturation pulses Fat
Fat suppression Yes
Scan time ∼5 min
Table A3.2.7 Primary Clinical Imaging Parameters for T1-Weighted Scan
(Sequence 7)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 11 msec (or select “minimum
full” echo time)
Receiver bandwidth (RBW) 10 kHz
Repeat time (TR) 600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.94 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 3 mm
Number of slices 20 or as many as needed to cover
entire skull base
Slice gap 0.5 mm
Number of acquisitions (Nacq) 3
Swap read and phase encoding Yes
Saturation pulses None
Fat suppression No
Scan time ∼5 min
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Sequence 6: T2-weighted scan
4. Run sequence 6 according to Table A3.2.6. Fat-suppressed high-resolution imaging
is essential to clearly delineate the full extent of disease in the skull base.
Sequence 7: T1-weighted scan
5. Run sequence 7 according to Table A3.2.7.
Sequence 8: T1-weighted scan (post-contrast)
6. Repeat steps 15 and 16 in Basic Protocol 1.
7. Post-contrast T1-weighted sequence 8 (Table A3.2.8) are obtained in two planes
(transverse and coronal). The entire extent of the lesion must always be included.
Fat-suppressed T1-weighted images are critical to evaluate for abnormal enhancement
of cranial nerves, since high signal intensity from fat found along the skull base or
chemical shift artifact from fat-containing structures can obscure enhancement of
cranial nerves.
8. In addition, post-contrast images (sequence 8 outlined in Table A3.2.8) of the entire
brain should be obtained.
BASIC
PROTOCOL 3
R/O HEMORRHAGIC METASTATIC DISEASE/MELANOMA
The MR appearance of hemorrhage will vary according to the stage of the hemorrhage
(acute-chronic) on the T1-weighted and T2-weighted images. On the other hand, gradient-
echo images not uncommonly demonstrate evidence of hemorrhage that may not be seen
with conventional spin-echo images (Atlas et al., 1987, 1988; Thulborn et al., 1990;
Thulborn and Atlas, 1996). Intracranial metastatic melanoma (if melanotic) exhibits the
typical imaging appearance of any paramagnetic lesion (Atlas et al., 1987), causing
shortening of T1 and T2. However, the imaging appearance may be quite variable
depending on melanin content and hemorrhage.
Table A3.2.8 Primary Clinical Imaging Parameters for Post-Contrast
T1-Weighted Scan (Sequence 8)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse and coronal
Central slice or volume center Laser light centered on nasion
Echo time (TE) 20 msec
Receiver bandwidth (RBW) 10 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.94 mm
Number of slices 20 or as many as needed to cover
the area of interest
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 3 mm
Slice gap 0.5 mm
Number of acquisitions (Nacq) 3
Swap read and phase encoding Yes if it is a transverse scan
Saturation pulses Fat
Fat suppression Yes
Scan time ∼5 min
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Set up equipment and patient
1. Use the same equipment and perform patient setup as in Basic Protocol 1. Obtain
sequences 1 to 4. 
In addition, gradient echo (GRE) images (sequence 9; Table A3.2.9) should be obtained.
Sequence 9: Gradient echo scan
2. Run sequence 9 according to Table A3.2.9.
Sequence 10: Post-contrast imaging
3. Run sequence 5 (see Basic Protocol 1, steps 15 to 17).
COMMENTARY
Background Information
Metastatic extra-axial disease is common in
clinical practice and lesions are frequently nu-
merous and infiltrative. Obtaining detailed in-
formation regarding the entire extent of disease
is critical to the planning of appropriate treat-
ment. MRI with intravenous contrast is essen-
tial for documenting meningeal disease and
spread along cranial nerves.
High-resolution computed tomography
(CT) of the skull base is often an integral part
of the work-up of a skull base lesion. CT pro-
vides important information regarding the in-
tegrity of bone architecture and depicts bone
irregularity, erosion, intra-tumoral calcification
or hyperostosis.
Critical Parameters and
Troubleshooting
The MR evaluation for extra-axial spread of
tumor to the meninges (leptomeningeal carci-
nomatosis) should always include FLAIR or
post-contrast T1-weighted images to provide
the greatest sensitivity in disease detection.
When evaluating the skull base, fat-suppressed
high-resolution imaging (including T2-
weighted and post-contrast T1-weighted) is es-
sential to clearly delineate the full extent of
disease. With a resolution of less than 1 mm in
the x and y directions, there is superb visuali-
zation of the fine, intricate structures of the
skull base (foramina and cranial nerves). Fat-
suppressed T1-weighted images are critical to
Table A3.2.9 Primary Clinical Imaging Parameters for Gradient Recalled Echo
(GRE) Scan (Sequence 9)
Patient position Supine
Scan type 2-D gradient recalled echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 30 msec
Receiver bandwidth (RBW) 4 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 15°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 or as many as needed to cover
the region of interest
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time ∼2 min
Current Protocols in Magnetic Resonance Imaging
A3.2.8
Metastatic
Extra-Axial
Neoplasia
evaluate for abnormal enhancement of cranial
nerves, since high signal intensity on the T1-
weighted images from fat found along the skull
base or chemical shift artifact from fat-contain-
ing structures can obscure enhancement of cra-
nial nerves. Inhomogeneities in the magnetic
field can result in incomplete fat suppression
or unintended suppression of water. With expe-
rience this does not usually represent a concern.
Anticipated Results
The goal of imaging when evaluating for
extra-axial metastases is to accurately localize
and detect the full extent of disease. Magnetic
resonance imaging offers the necessary con-
trast and high resolution to fully evaluate the
extra-cranial compartment for tumor spread.
Time Considerations
The majority of these protocols should take
∼30 min to complete.
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